CTRI/2024/02/063118尚未招募3 期
PRe-operative ChemoTherapy versus Surgery first with peri-operative interventions in Early triple negative and HER2 enriched breast- an open label, phase 3, randomized controlled trial (PRaCTiSE) - PRaCTiSE
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Histologically proved breast carcinoma
- •2.Triple negative(ER, PgR, HER2-neu) and HER2-neu positive (ER/PgR +/-)
- •3.T1-2 (excluding T1a), N0-1 (non-metastatic)
- •4. > 18 years < 65 years
- •5.ECOG 0-1
- •6.Written informed consent
- •7.Fit for surgery or chemotherapy
排除标准
- •1.Pregnant, lactating women
- •2.Previous h/o breast or any other non-skin malignancy
- •3.Previous treatment for excision biopsy/other cancer.
- •4.History of allergy to Inj. Lignocaine
研究者
相似试验
尚未招募
3 期
pfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cavity Squamous Cell CancersCTRI/2024/03/064586Indian Council of Medical Research
招募中
不适用
Effect of preoperative concurrent chemoradiotherapy in patients with adenocarcinoma of esophagusCTRI/2013/09/003981not applicable160
进行中（未招募）
不适用
Study of Upfront surgery versus Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery for Patients with Stage IIIC and IV Ovarian CancerNeoplasmsKCT0005870Seoul National University Hospital456
招募中
3 期
Cancer injection before surgery vs after surgery in stomach cancerCTRI/2021/01/030183Jawaharlal Institute of Postgraduate Medical Education and Reserach
进行中（未招募）
1 期
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224